Rationale In gestational exposure studies, a fostered group is frequently used to control for drug-induced maternal effects. However, fostering itself has varying effects depending on the parameters under investigation Objectives This study was designed to assess whether maternal behavior contributed to enhanced acquisition (higher number of bar presses compared to controls) of nicotine self-administration (SA) displayed by offspring with gestational nicotine and ethanol (Nic+EtOH) exposure. Methods Offspring were exposed to Nic+EtOH throughout full gestation, that is, gestational days (GD) GD2-20 and during postnatal days 2-12 (PN2-12), the rodent third trimester equivalent of human gestation during which rapid brain growth and synaptogenesis occur. Young adult (PN60) male offspring acquired operant nicotine SA, using a model of unlimited (i.e., 23 h) access to nicotine. Results Gestational drug treatments did not alter litter parameters (body weight, volume distribution, crown-rump length, and brain weight) or postnatal growth of the offspring. Fostering increased locomotor activity to a novel environment on PN45 regardless of gestational treatment group. Surprisingly, fostering per se significantly increased the SA behavior of drug-naïve pair-fed controls, so that their drug-taking behavior resembled the enhanced nicotine SA observed in non-fostered offspring exposed to Nic+EtOH during gestation. In contrast, fostering did not change the SA behavior of the Nic+EtOH group. Conclusions Fostering is shown to be its own experimental variable, ultimately increasing the acquisition of nicotine SA in control, drug-naïve offspring. As such, the current dogma that fostering is required for our gestationally drugexposed offspring is contraindicated.
Introduction
Drug exposure during pregnancy has long been reported to negatively affect the development of the fetal brain (Stanwood and Levitt 2004) . Maternal behavior in the postnatal environment is also known to play an important role in determining offspring behavior in adolescence and adulthood (Barbazanges et al. 1996) . Fostering offspring to drug-naïve dams has long been considered necessary to control for lingering drug effects on the dam that may further alter offspring growth and development (Abel and Dintcheff 1978; Golub and Kornetsky 1975) . It has become almost dogma in the literature that maternal prenatal drug exposure is a negative contributor to subsequent maternal-offspring interaction. This has resulted in the implementation of fostering as a standard practice without actual empirical testing of the effect that fostering itself may exert.
Our laboratory has previously shown that young adult male rats exposed to nicotine and ethanol (Nic+EtOH) throughout full gestation (i.e., gestational days (GD)) GD2-20 and during postnatal days 2-12 (PN2-12), the rodent third trimester equivalent of human gestation during which rapid brain growth and synaptogenesis occur (Dwyer et al. 2009; Puglia and Valenzuela 2010) , exhibit increased acquisition of nicotine self-administration (SA) behavior (Matta and Elberger 2007) . In addition, there were no significant differences in standard birth parameters between Nic+EtOH offspring and controls (Matta and Elberger 2007) . Regardless, a frequent concern of grant and manuscript reviewers is adherence to the literature standard that insists on fostering/cross-fostering all offspring to surrogate dams. With careful examination of the historical literature on gestational drug treatment protocols, it appears that the requirement of fostering has been based, at least in part, on studies of fetal alcohol syndrome (FAS) . In such studies, the pregnant/nursing dam received gavaged EtOH at doses that raised her blood ethanol concentration (BEC) to approximately 340 mg/dl or greater (Abel and Dintcheff 1978) , doses rarely seen in the human population. In these reports, the dams that did manage to survive the EtOH dosing showed significant intoxication, including staggering gait, slowed respiration, and in many cases comatose behavior that lasted for >2 h. Offspring that survived this dosing protocol were born late, had low birth weights, and showed delayed maturation parameters (Eppolito and Smith 2006) . Obviously, maternal-offspring interactions were compromised. In contrast, our dosing protocol produced BECs of approximately 150 mg/dl and the dams showed no differences in retrieval or covering behavior (data not shown).
The aim of the current study was to determine whether fostering would modify the increased acquisition of nicotine SA behavior, previously seen in offspring with full gestational (GD2-PN12) exposure to Nic+EtOH compared to pair-fed (PF) controls.
Based on the complete lack of differences in litter parameters reported by Matta and Elberger (2007) , we felt it was critical to determine if the increased SA behavior of the Nic+EtOH offspring compared to PF controls was the due to the effect of the drugs on the developing pups or the indirect effect of changes in maternal-offspring interaction.
We found that fostering itself has a significant effect on locomotor activity regardless of gestational treatment. Surprisingly, fostering increased nicotine SA only in the fostered PF controls, so the behavior resembled to that seen in the drug-treated Nic+EtOH offspring. Therefore, our results show that fostering itself can contribute to altered behavior in the offspring, demonstrating that fostering is not a neutral control. Rather, it should be considered a unique experimental condition that specifically interacts with other treatments.
Materials and methods

Breeding and gestational drug exposure
The model of gestational exposure was conducted as described in Matta and Elberger (2007) . Briefly, SpragueDawley rats (Harlan, IN, USA) were group housed with a reverse light cycle (11 a.m. off and 11 p.m. on). Female rats were paired with male breeders overnight and then randomly assigned to the experimental Nic+EtOH group or the controls (nicotine-alone or PF groups) on sperm positive day 1 (GD1). Pair feeding was accomplished by providing the control dams with the same amount of food consumed by the Nic+EtOH dam on the same gestational day. For prenatal drug exposure of the experimental Nic+EtOH group, EtOH was administered by daily gastric gavage of 4 g/kg from GD2 until GD20 and nicotine 2 mg/kg/day (pH=7.2; calculated as free base; (−)-nicotine hydrogen tartrate salt; Sigma-Aldrich Co., St. Louis, MO, USA) was delivered by a mini-osmopump (Alzet 2ML4; Durect, Cuppertino, CA, USA) implanted on GD3 (Fig. 1a) . For prenatal exposure in PF dams, isocaloric maltose dextran (MD) was gavaged, instead of EtOH, and dams received a water-filled mini-osmopump (Fig. 1b) . Prenatal nicotinealone dams were gavaged with MD and fitted with a 2-mg/kg/day nicotine mini-osmopump, to serve as the surrogate for Nic+EtOH offspring (Fig. 2a) . After birth (PN0), litters were randomly culled to ten pups (five females + five males when possible) on PN1 and drug treatments continued from PN2 to PN12, the rodent equivalent of the human third trimester. For both fostered and non-fostered Nic+EtOH offspring, the nicotine mini-osmopump in their dam (Nic+ EtOH and nicotine-alone) was replaced on PN2 with one containing 8 mg/kg/day, in order to deliver sufficient nicotine to the pups through the dams' milk, as reported previously (Matta and Elberger 2007) ; EtOH was delivered by gavaging the offspring twice daily, 30 min apart, for a total of 4 g/kg (Fig. 1a) . The non-fostered PF pups received two isocaloric MD gavages daily and nursed from their own dam, fitted with a new water mini-osmopump replaced on PN2 to control for surgical effects (Fig. 1b) . All offspring were weaned at PN21, group housed by litter, and allowed to mature with unrestricted access to food and water until they were single housed starting on PN60 for nicotine SA experiments. Daily handling and pseudo-gavaging of dams prior to pregnancy minimized stress. The pups were never separated from their littermates, except when an individual pup was being gavaged (<1.5 min); each litter was returned to its dam within 5-6 min at which time every dam recollected and covered her litter regardless of treatment group. All procedures were conducted in accordance with the NIH Guidelines for the Use and Care of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of Tennessee Health Science Center.
Fostering
The fostering of the offspring was completed between PN1 and PN2. Surrogate dams were timed to deliver at the same time as Nic+EtOH or PF litters. Since the experimental paradigm requires a three-trimester equivalent drug exposure, postnatal Nic+EtOH offspring could not be fostered to a drug-naïve dam because the drug-naïve dam would have adverse reactions to the sudden exposure to an 8-mg/kg/day nicotine mini-osmopump on PN2, which is required to deliver the appropriate dose of nicotine to the pups via the dams' breast milk (Matta and Elberger 2007) . Therefore, the fostered Nic+EtOH pups were placed with the nicotine- a Dams designated as Nic+EtOH received EtOH gavages (4 g/kg) beginning on GD2 and a nicotine miniosmopump (2 mg/kg/day) implantation on GD3. Offspring were fostered on PN1-2 to a surrogate dam that received prenatal nicotine exposure (nicotine-alone group) and whose pups were terminated at fostering. Postnatal exposure to EtOH began on PN2 with twice daily gavages of EtOH (4 g/kg total) to each offspring. Nicotine exposure was administered by replacing the nicotine pump (8 g/kg) in the surrogate dam, so that the pups received nicotine through the dams' milk. b PF offspring were fostered to different PF dams on PN1-2. Postnatal exposure for the offspring was given by twice daily gavages of MD (4 g/kg total) beginning on PN2 and a replacement control mini-osmopump on PN2 in the surrogate Fig. 1 Protocol for drug treatments in non-fostered offspring. a Dams designated as Nic+EtOH on GD1 received EtOH gavages (4 g/kg) beginning on GD2 and a nicotine mini-osmopump (2 mg/kg/day) implantation on GD3. The non-fostered pups remained with their dam postnatally. Postnatal exposure to EtOH began on PN2 with twice daily gavages of EtOH (4 g/kg total) to each pup. Nicotine exposure was administered by replacing the nicotine pump (8 g/kg) in the dam, so that the pups received nicotine through the dams' milk. b PF dams received daily gavages beginning on GD2 of MD (4 g/kg) and a control mini-osmopump of water on GD2. These non-fostered pups also remained with their dam postnatally. Postnatal pup exposure with twice daily gavages of MD (4 g/kg total) began on PN2 and a replacement control mini-osmopump was inserted in their dam on PN2 alone surrogate dam that had been exposed to 2 mg/kg nicotine prenatally (GD1-21) and gavaged daily with MD; these Nic+EtOH pups were gavaged with EtOH daily (Fig. 2a) . All the offspring from these designated nicotine-alone surrogates were sacrificed at the time that the experimental Nic+EtOH offspring were fostered to those dams. Fostered PF offspring were placed with a new PF dam that received a new water mini-osmopump on PN2 and the pups received MD from P2 to P12 (Fig. 2b) .
Litter parameters
In addition to those previously reported (Matta and Elberger 2007) , additional litter parameters were measured on PN1 to determine if there were developmental alterations due to gestational drug treatment. Pups with in utero exposure to Nic+EtOH or PF (n=9 each) from five Nic+EtOH litters and four PF litters were used to measure body weight (Bwt), volume distribution, crown-rump length, and brain weight. After Bwt measurement, the volume of water displaced when the pup was placed in a cylinder of water was determined, followed by measuring the length from the crown of the head to the beginning of the tail, and then, the brain was removed and weighed. Since there were no sex differences in these (or the previous) parameters, the data were pooled.
Locomotor activity Activity in a novel environment was measured for adolescent male offspring (PN45) with a MicroMax monitoring system (AccuScan Instruments, Columbus, OH, USA). Rats were placed in individual chambers (45×24×19 cm) with dividers preventing each rat from observing the others. Data were collected in 5-min increments during 1 h with the lights off.
Nicotine self-administration Young adult male offspring (PN60-75) were allowed chronic, almost unlimited (i.e., 23 h/day) access to bar press for nicotine without prior training, shaping, or food deprivation, using our established model (Valentine et al. 1997) . Briefly, after implantation of a jugular cannula, rats were placed into individual operant chambers (Coulbourn Instruments, Allentown, PA, USA) enclosed in ventilated, sound-attenuating environmental boxes. The jugular line was connected to a microinjection pump (Med Associates, St. Albans, VT, USA) by a single channel swivel (Instech, Plymouth Meeting, PA, USA). Rats were given 3 days to recover from surgery; thereafter, the rats were provided free access for 23 h daily (1 h daily is required for animal husbandry and downloading data) to two randomly assigned levers positioned 5 cm above the floor, each with a green light above signaling the availability of the drug. Pressing the active lever ("active") signaled the computer (Graphic State Notation Software, Coulbourn Instruments) to activate a pump that delivered 30 μg/kg nicotine in a 50-μl heparinized saline bolus over 0.81 s on a fixed ratio (FR1) schedule with a 7-s delay; pressing the inactive lever ("inactive") had no programmed consequence. Self-administration day 1 (d1) was the first day that nicotine was made available and the offspring were given 10 days free access to acquire nicotine SA on an FR1 schedule.
As per our previously reported criteria for this open access model (Valentine et al. 1997) , acquisition of nicotine self-administration behavior to maintenance criteria was defined by: (1) stabilization of the number of active bar presses on the final 3 days to within 15 % variation, (2) active bar presses greater than inactive presses, and (3) active presses greater than 12/day.
Statistics
Three-way ANOVA analyses were completed for SA, locomotor activity, and the offspring growth curve to examine the interaction between cohort and fostering. One-way ANOVA analysis was completed for litter parameters with a Scheffe post hoc comparison using SPSS software; significance was set at p<0.05. To reduce the number of animals used, once statistical significance was achieved, further rats were not tested. Values are mean±SEM and the number of animals/group is indicated within parentheses in the text and figures.
Results
Litter parameters
Litter parameters were measured on PN1 using two pups per treatment group for Nic+EtOH (n=9) and PF cohorts (n=9; Table 1 ). These parameters were chosen because they are indicators of exposure to doses of gestational EtOH, used in models of FAS; such doses are greater than that administered in the current study. In marked contrast to reports on FAS, there were no differences in volume distribution, crown-rump length, or brain weight for Nic+EtOH or their PF controls. Similar to previous observations (Matta and Elberger 2007) , there was no significant difference in the birth weight between the Nic+EtOH and PF offspring. In addition, peak BECs in Nic+EtOH dams and their offspring (154±6 and 151±6 mg/dl, respectively) were comparable to those commonly reported in humans cited for a DWI (i.e., driving while intoxicated) violation (Matta and Elberger 2007) . Also, peak plasma nicotine levels (30±3 and 21±2 ng/ml, respectively) were lower than those eliciting nicotine-induced hypoxia (Slotkin et al. 1987 ). These data demonstrate that offspring were exposed to moderate doses of EtOH similar to those frequently imbibed by human binge drinkers and moderate smokers. Taken together, these data indicate that gestational drug treatment did not alter general indices of offspring health.
Offspring growth curve Figure 3 illustrates postnatal body weight gain among treatment groups. Fostering had no effect on body weight gain in the Nic+ EtOH offspring nor did it alter weight gain in the PF offspring; weight gain was similar in both treatment groups (p=0.27). These data demonstrate that neither fostering nor drug treatments altered growth during postnatal drug administration.
Locomotor activity
Fostered Nic+EtOH and PF offspring had a higher total activity over the 1-h session on PN45 compared to nonfostered Nic+EtOH and PF offspring (F 1, 348 =4.1, p<0.05) (Fig. 4) . Similarly, the non-fostered offspring (Nic+EtOH and PF) did not differ significantly from each other nor did the fostered Nic+EtOH and PF offspring behaviors differ.
Nicotine SA To demonstrate that offspring learned the SA behavior, active vs. inactive lever presses were compared. Both nonfostered and fostered PF rats expressed significantly higher active lever presses compared to inactive lever presses for the entire 10-day period of nicotine SA behavior: PF nonfostered offspring (F 1, 100 =97.36, p<0.01), PF fostered (F 1, 100 =150.68, p<0.01). Surprisingly, the fostered PF offspring had significantly increased nicotine SA compared to non-fostered PF offspring (F 1, 100 =16.55, p<0.01) (Fig. 5a) . Furthermore, fostered offspring acquired the behavior by d4 (p<0.05, active vs. inactive bar presses by day), while nonfostered required a longer time interval (d8; p<0.05, active vs. inactive presses by day). Fostered PF offspring also exhibited significantly more bar presses than the nonfostered group during the last 3 days: 77±8 vs. 50±8 for fostered vs. non-fostered, respectively (F 1, 34 =5.7, p=0.02).
In contrast, Fig. 5b shows that fostering Nic+EtOH offspring did not alter their SA behavior (p=0.99 for Nic+ EtOH vs. Nic+EtOH fostered). Active bar presses were greater than inactive presses in both groups: non-fostered Nic+EtOH offspring (F 1, 120 =136.91, p<0.01) and Nic+ EtOH fostered (F 1, 120 =70.67, p<0.01; data not shown). Non-fostered Nic+EtOH, fostered Nic+EtOH, and fostered PF offspring showed significantly higher levels of nicotine SA in comparison to non-fostered PF offspring (active bar presses: F 1, 220 =6.62, p<0.01). 
Discussion
Our data show that early postnatal fostering per se markedly increased nicotine SA in young adult PF offspring-the control group for Nic+EtOH full gestational treatment. These results indicate that the alteration of postnatal environment (i.e., maternal behavior; maternal grooming, nursing, etc.) increases the long-term drug-taking behavior of the offspring.
There is a limitation of the three-trimester model of full gestational drug exposure, which was designed to approximate full three-trimester exposure in humans. During the third trimester (i.e., postnatally) in this model, we have attempted to approximate the continuous exposure of the postnatal pups to the blood nicotine levels they had while in utero. In contrast, since the EtOH was administered to the pregnant dams as a binge dose, we also administered the EtOH to the postnatal pups as a binge dose in order to control for BEC. That is, even if we had gavaged the nursing dam, there was no way we could guarantee that each individual pup would drink sufficient breast milk with EtOH within the timeframe of EtOH metabolism in the dam.
Full gestational exposure to relatively moderate amounts of both nicotine and EtOH did not alter birth parameters (PN1) or body weight gain in offspring (PN1-PN21) compared to PF controls. These results are in agreement with our previous report in which sex ratio, stillbirths, righting reflex, and the day of eye opening were similar between all treatment groups (Matta and Elberger 2007) . Previous studies have shown that gestational EtOH exposure (4 and 6 g/kg) was associated with low birth weight and behavioral abnormalities in the offspring (Abel 1978; Abel and Dintcheff 1978) . However, the outcome of low birth weight was inconsistent, even following relatively high doses of 6 g/kg (Caul et al. 1979; Matta and Elberger 2007; Osborne et al. 1980) ; this could reflect differences in the mode of EtOH delivery or rat strain. Prenatal nicotine exposure has also been associated with low birth weight of pups; however, this is seen only at higher doses (>6 mg/kg/day) and not at the lower dose used herein (i.e., 2 mg/kg/day) (Eppolito and Smith 2006; Navarro et al. 1989; Slotkin et al. 1987) . Depending on drug and dose, prenatal drug exposure also may modify aspects of the postnatal environment. It has been shown that offspring with prenatal EtOH exposure fail to gain weight at the same rate as the control offspring after being born with low birth weight, and this lack of weight gain was thought to be attributed to factors in the postnatal environment (i.e., the drug-exposed dam) and not to the prenatal EtOH exposure itself (Abel and Dintcheff 1978) . In contrast, crossfostering of control offspring to EtOH-exposed dams did not alter the weight gain of these offspring, demonstrating that the EtOH-treated dams themselves did not adversely affect the growth of the offspring (Osborne et al. 1980) . Despite the lack of any correlation between drug exposure in dams and offspring behavior, the authors of that early report still strongly recommended fostering to drug-naïve dams. However, our results show that regardless of gestational treatment (Nic+ EtOH or PF), the postnatal growth curves for non-fostered offspring were consistent with our previous report (Matta and Elberger 2007) and did not differ from each other. Taken together, these data indicate that neither fostering nor gestational drug treatment altered the overall bodily growth and gross CNS maturation of offspring.
Fostering at different postnatal time points can exert divergent effects on behavior (Barbazanges et al. 1996; Darnaudery et al. 2004) . It has been reported that maternal separation stress in early human life dysregulates the hypothalamic-pituitary-adrenal (HPA) stress axis, thus increasing the risk for drug-taking behavior (Andersen and Teicher 2009; Vallee et al. 1999) . Also, rat offspring fostered at PN5 Fig. 5 a In the PF control young adult offspring, fostering alone significantly increased nicotine SA. PF offspring, both fostered and non-fostered, were given 23-h access to acquire self-administration of 30 μg/kg/inj of nicotine without priming, shaping, or training. Fostering increased lever presses on the active bar delivering nicotine 30 μg/ kg/inj (solid line), without affecting behavior on the inactive bar (no consequences lever; dashed line); *p<0.05, active bar presses, PF nonfostered vs. PF fostered. b Fostering had no effect on the nicotine SA by the Nic+EtOH young adult offspring. Full gestational exposure (GD2-PN12) to Nic+EtOH resulted in increased levels of nicotine SA, as well as a shortening in the onset of initiation of nicotine SA, regardless of fostering status. Surprisingly, PF controls that had been fostered, but had no gestational drug exposure, demonstrated comparable levels of nicotine SA to Nic+EtOH offspring or PN12 displayed enhanced stress responses, similar to those detected in offspring exposed to maternal separation at the same time intervals (Barbazanges et al. 1996) . However, offspring fostered at PN1 did not display these increased stress responses (Darnaudery et al. 2004) . In rodents, prolonged maternal separation stress (3 h) at different postnatal ages increased subsequent dopamine responses to stress or stimulants in the mesocorticolimbic reward pathway (Brake et al. 2004 ). This reward pathway, which includes the ventral tegmental area, nucleus accumbens, and medial prefrontal cortex, is essential to the acquisition of drug self-administration (Koob and Nestler 1997) . In addition to reported alterations in the HPA axis, altered maternal-offspring interactions also can affect components of this reward pathway. For example, repeated or acute separation stress (1-3 h/daily from PN3 to PN21) altered multiple neuronal circuits. Specifically, 1-h separation from PN1 to PN20 increased serotonin levels and serotonin turnover (5-HIAA/5HT ratio) in medial prefrontal cortex and hippocampus (Jezierski et al. 2006) , while 1-h separation from PN1 to PN21 increased GABA in the medial prefrontal cortex (Helmeke et al. 2008 ). Finally, a recent report (Champagne and Curley 2009) showed that cross-fostering of drug-naïve WKY pups to a spontaneously hypertensive rat (SHR) surrogate caused a shift in phenotype to that of SHR. Studies in progress are centered on the modulation of GABAergic inhibition and glutamatergic excitation in the VTA of the Nic+ EtOH offspring, as well as specific epigenetic changes, such as DNA methylation in these neuronal types.
The fostering/cross-fostering of offspring and the resultant locomotor activity have been reported to produce varied results. While offspring fostered on PN1 did not differ from controls, groups with maternal separation from the dam had higher locomotor response (Barbazanges et al. 1996) . Adult rats fostered at later neonatal time points (PN5 or PN12) had a significantly higher locomotor responses compared to non-fostered offspring (Barbazanges et al. 1996) . Also, it has been reported that neither fostering nor cross-fostering of Wistar and Fisher rats altered total motor activity for open field behavior. In contrast, a report on the cross-fostering of Lewis and Fisher strains demonstrated significant differences in locomotor activity for both males and females, whereas in-strain fostering of the offspring produced no differences in activity (Gomez-Serrano et al. 2001 ). Locomotor activity to a novel environment has been used in the past to separate animals into higher anxiety vs. lower anxiety responder groups (Gancarz et al. 2011) . High responder groups of younger rats (4 months old) have been associated with increased HPA axis activity in response to stress (Dellu et al. 1996) . Responding for nicotine, methamphetamine, and even visual stimulus has also been correlated with high locomotor response to novelty (Gancarz et al. 2011; Suto et al. 2001) . Our locomotor results show that only fostered offspring, regardless of full gestational treatment group, had an increased response to a novel environment in adolescence. In addition, the inactive lever presses during selfadministration did not increase with prenatal drug exposure or fostering, therefore demonstrating that offspring were not hyperactive in the SA chambers. We conclude from this that increased locomotor activity in a novel environment is not necessarily a predictor of a high nicotine self-administration.
In our study, we did not expect to see behavioral changes, since the PF control offspring were fostered on PN1 and there were no differences in litter parameters. Yet, we found dramatic increases in the nicotine SA behavior of fostered PF offspring that was comparable to the behavior of experimental offspring with full gestational exposure to Nic+EtOH. Selfadministration behavior of the non-fostered PF offspring remained consistent with data previously reported (Matta and Elberger 2007) . Active bar presses were less in non-fostered than fostered PF (e.g., 50±8 vs. 77±8) and acquisition time was longer (i.e., 8 days compared to 4 days for Nic+EtOH). Therefore, fostering alone, even in the absence of gestational exposure to drugs, is sufficient to alter nicotine SA behavior.
In contrast, fostering itself did not change the enhanced nicotine SA behavior of Nic+EtOH pups. There were no differences in the number of active bar presses, in the ratio of active to inactive presses, or in the number of days to acquire stable nicotine SA. The lack of any effect of fostering in these pups could be due, at least in part, to a maximal or "ceiling" effect of gestational drug treatment on the developing brain of Nic+EtOH offspring.
Variability in the effect of fostering has been reported for various drugs. Rats with prenatal methamphetamine exposure (5 mg/kg/day) show improvement in maturation tests when fostered to drug-naïve dams (Pometlova et al. 2009 ). Similarly, while non-fostered rat offspring with in utero saline or morphine exposure (5 mg/kg injection GD11-13, 10 mg/kg GD14-18) did not exhibit higher operant response rates for cocaine (0.5 mg/kg/inj) compared to controls, fostering itself increased responding for cocaine regardless of prenatal treatment group (Vathy et al. 2007 ). In our previous study, crossfostering of offspring with prenatal nicotine exposure (3 mg/kg/day) did not affect the increase in the dopaminergic response to a nicotine injection. However, cross-fostering of controls resulted in an increase in accumbal dopamine similar to that seen in offspring with prenatal nicotine exposure (Kane et al. 2004 ). These studies, as well as our data herein, support the idea that the fostering procedure itself, assumed to reduce negative maternal effects by many, is contraindicated and may actually introduce new sources of variance, subsequently changing pup behavior (Darnaudery et al. 2004) .
In summary, fostering of PF offspring significantly increased the nicotine SA behavior in young adult rats without altering the enhanced SA behavior of the Nic+EtOH offspring. Indeed, the experimental practice of fostering alone elevated the nicotine self-administration behavior of PF offspring to levels comparable to these Nic+EtOH rats. Therefore, in the current model of unlimited (i.e., 23 h) nicotine access, fostering introduces a major confound that precludes its use as a control for environmental interactions during the neonatal period for our full gestational model of Nic+EtOH exposure. Thus, the dogmatic assertion that fostering is a crucial control is inaccurate, rather fostering is its own experimental variable.
